Lingda Group
300125
SEP Analytical
301228
ChengDu Sheng Nuo Biotec
688117
4
Guangxi Hechi Chemical
000953
5
Xiangcai Co.,Ltd
600095
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.72%545.53M | 15.92%148.55M | 19.15%141.7M | 19.45%132.6M | 16.49%122.69M | 21.65%463.41M | 30.67%128.15M | 14.83%118.93M | 16.10%111.01M | 25.88%105.33M |
Operating revenue | 17.72%545.53M | 15.92%148.55M | 19.15%141.7M | 19.45%132.6M | 16.49%122.69M | 21.65%463.41M | 30.67%128.15M | 14.83%118.93M | 16.10%111.01M | 25.88%105.33M |
Cost of revenue | 15.70%329.91M | 13.24%89.53M | 18.16%85.87M | 18.18%79.72M | 13.39%74.79M | 21.38%285.15M | 24.29%79.06M | 15.97%72.68M | 16.46%67.45M | 30.01%65.96M |
Gross profit | 20.96%215.62M | 20.24%59.02M | 20.71%55.83M | 21.40%52.88M | 21.67%47.9M | 22.10%178.26M | 42.46%49.09M | 13.08%46.25M | 15.55%43.56M | 19.52%39.37M |
Operating expense | 8.05%271.69M | 14.34%70.46M | 13.51%67.31M | -4.52%68.17M | 11.21%65.76M | 13.13%251.44M | 0.34%61.62M | 6.31%59.3M | 34.25%71.39M | 13.95%59.13M |
Selling and administrative expenses | 5.34%173.39M | 10.61%44.03M | 13.40%43.26M | -8.86%43.98M | 9.70%42.12M | 15.42%164.6M | -2.01%39.81M | 4.40%38.15M | 45.32%48.25M | 19.08%38.4M |
-Selling and marketing expense | 15.74%108.44M | 4.62%26.55M | 17.21%27.2M | 21.27%27.49M | 21.22%27.2M | 11.04%93.69M | -0.60%25.37M | 8.38%23.21M | 24.92%22.67M | 16.35%22.44M |
-General and administrative expense | -8.40%64.96M | 21.13%17.49M | 7.50%16.06M | -35.55%16.49M | -6.49%14.92M | 21.75%70.92M | -4.41%14.44M | -1.23%14.94M | 69.90%25.58M | 23.13%15.96M |
Research and development costs | 14.10%39.32M | 16.62%10.37M | 9.63%9.34M | 12.28%10.02M | 18.03%9.59M | 11.12%34.46M | 6.94%8.89M | 11.95%8.52M | 14.44%8.92M | 11.45%8.13M |
Other operating expenses | 12.61%58.98M | 24.26%16.06M | 16.45%14.7M | -0.33%14.17M | 11.41%14.05M | 7.70%52.37M | 3.62%12.92M | 8.62%12.62M | 16.75%14.22M | 2.02%12.61M |
Operating profit | 23.38%-56.07M | 8.76%-11.44M | 12.00%-11.48M | 45.07%-15.29M | 9.63%-17.86M | 4.05%-73.18M | 53.49%-12.54M | 12.29%-13.05M | -79.78%-27.83M | -4.26%-19.76M |
Net non-operating interest income expense | -11.62%6.03M | -25.52%1.32M | -10.90%1.59M | -10.87%1.57M | 3.07%1.54M | 2,351.82%6.82M | 85.45%1.77M | 1,092.67%1.79M | 340.27%1.77M | 322.44%1.5M |
Non-operating interest income | -7.11%10.78M | -15.28%2.51M | -7.11%2.78M | -6.66%2.76M | 1.37%2.73M | 182.07%11.61M | 34.44%2.96M | 122.77%2.99M | 524.26%2.96M | 2,707.29%2.7M |
Non-operating interest expense | -0.67%4.75M | 0.00%1.19M | -1.49%1.19M | -0.42%1.19M | -0.75%1.19M | 8.28%4.78M | -4.65%1.19M | 0.92%1.21M | -1.32%1.19M | 55.79%1.2M |
Other net income (expense) | 73.53%-387K | 153.18%184K | 54.07%-282K | 100.18%1K | -617.86%-290K | 40.01%-1.46M | 59.77%-346K | -93.69%-614K | -68.07%-558K | 106.03%56K |
Earnings from equity interest | 1.35%452K | -555.56%-41K | 20.90%162K | -1.27%234K | 46.97%97K | -21.75%446K | 130.00%9K | -54.88%134K | -11.90%237K | 94.12%66K |
Special income (charges) | 79.35%-82K | ---82K | --0 | --0 | --0 | 51.82%-397K | --0 | 53.54%-151K | -84.03%-219K | ---27K |
-Write off | -79.35%82K | --82K | --0 | --0 | --0 | -51.82%397K | --0 | -53.54%151K | 84.03%219K | --27K |
Other non- operating income (expenses) | 49.90%-757K | 186.48%307K | 25.63%-444K | 59.55%-233K | -2,376.47%-387K | 30.78%-1.51M | 21.11%-355K | -106.57%-597K | -19.50%-576K | 101.77%17K |
Income before tax | 25.65%-50.42M | 10.59%-9.94M | 14.34%-10.17M | 48.49%-13.71M | 8.80%-16.6M | 14.16%-67.82M | 58.63%-11.11M | 21.08%-11.87M | -60.89%-26.63M | 11.42%-18.21M |
Income tax | 94.05%-21K | 92.69%-41K | -78.42%30K | 85.07%-10K | 0 | -1,080.56%-353K | -194.29%-561K | 139K | -67K | 124.33%136K |
Net income | 25.29%-50.4M | 6.23%-9.9M | 15.08%-10.2M | 48.40%-13.7M | 9.48%-16.6M | 14.65%-67.47M | 61.57%-10.55M | 20.15%-12.01M | -60.49%-26.56M | 8.26%-18.34M |
Net income continuous Operations | 25.29%-50.4M | 6.23%-9.9M | 15.08%-10.2M | 48.40%-13.7M | 9.48%-16.6M | 14.65%-67.47M | 61.57%-10.55M | 20.15%-12.01M | -60.49%-26.56M | 8.26%-18.34M |
Minority interest income | -128.57%-2K | -250.00%-7K | 0 | -40.00%-7K | 1,100.00%12K | -56.25%7K | -100.00%-2K | 425.00%13K | -225.00%-5K | -94.12%1K |
Net income attributable to the parent company | 25.30%-50.4M | 6.27%-9.89M | 15.17%-10.2M | 48.42%-13.7M | 9.42%-16.62M | 14.66%-67.47M | 61.57%-10.55M | 20.04%-12.02M | -60.42%-26.55M | 8.33%-18.34M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 25.30%-50.4M | 6.27%-9.89M | 15.17%-10.2M | 48.42%-13.7M | 9.42%-16.62M | 14.66%-67.47M | 61.57%-10.55M | 20.04%-12.02M | -60.42%-26.55M | 8.33%-18.34M |
Basic earnings per share | 26.95%-1.03 | 9.09%-0.2 | 16.00%-0.21 | 49.09%-0.28 | 10.53%-0.34 | 16.07%-1.41 | 56.86%-0.22 | 21.88%-0.25 | -57.14%-0.55 | 11.63%-0.38 |
Diluted earnings per share | 26.95%-1.03 | 9.09%-0.2 | 16.00%-0.21 | 49.09%-0.28 | 10.53%-0.34 | 16.07%-1.41 | 56.86%-0.22 | 21.88%-0.25 | -57.14%-0.55 | 11.63%-0.38 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |